These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12693740)

  • 1. Pharmacogenomics of congestive heart failure.
    Baliga RR; Narula J
    Med Clin North Am; 2003 Mar; 87(2):569-78, xiv. PubMed ID: 12693740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.
    Wheeler MT; Ho M; Knowles JW; Pavlovic A; Ashley EA
    J Cardiovasc Transl Res; 2008 Mar; 1(1):25-36. PubMed ID: 20559955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of heart failure -- focus on drug disposition and action.
    Cascorbi I; Paul M; Kroemer HK
    Cardiovasc Res; 2004 Oct; 64(1):32-9. PubMed ID: 15364611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of pharmacogenetics in the treatment of heart failure.
    Anwar MS; Iskandar MZ; Parry HM; Doney AS; Palmer CN; Lang CC
    Pharmacogenomics; 2015 Nov; 16(16):1817-27. PubMed ID: 26555119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of pharmacogenomics in the treatment of patients with heart failure.
    Feldman AM
    Ann Thorac Surg; 2003 Dec; 76(6):S2246-53. PubMed ID: 14667694
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics and pharmacogenetics in heart failure.
    Snyder EM; Olson TP; Johnson BD
    Curr Heart Fail Rep; 2007 Sep; 4(3):139-44. PubMed ID: 17883989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Has the time come for genetic diagnostics in heart failure?].
    Straburzyńska-Migaj E
    Kardiol Pol; 2007 Jan; 65(1):63-70. PubMed ID: 17295164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of heart failure in the course of coronary artery disease--the role of genetic factors].
    Kozieradzka A; Kamiński K; Musiał WJ
    Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S440-9. PubMed ID: 20527399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin gene polymorphisms and neurohormonal inhibition.
    Pauly DF
    Heart Fail Clin; 2010 Jan; 6(1):25-6. PubMed ID: 19945057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State of play of pharmacogenetics and personalized medicine in heart failure.
    Parry HM; Doney AS; Palmer CN; Lang CC
    Cardiovasc Ther; 2013 Dec; 31(6):315-22. PubMed ID: 23480579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure pharmacogenetics: past, present, and future.
    Davis HM; Johnson JA
    Curr Cardiol Rep; 2011 Jun; 13(3):175-84. PubMed ID: 21416259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of heart failure.
    Mestroni L; Begay RL; Graw SL; Taylor MR
    Curr Opin Cardiol; 2014 May; 29(3):227-34. PubMed ID: 24717669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and cardiovascular disease: impact on drug response and applications to disease management.
    Humma LM; Terra SG
    Am J Health Syst Pharm; 2002 Jul; 59(13):1241-52. PubMed ID: 12116890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of heart failure: a systematic review.
    Mottet F; Vardeny O; de Denus S
    Pharmacogenomics; 2016 Nov; 17(16):1817-1858. PubMed ID: 27813451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics for neurohormonal intervention in heart failure.
    McNamara DM
    Heart Fail Clin; 2005 Apr; 1(1):141-50. PubMed ID: 17386840
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart failure and personalized medicine.
    Mestroni L; Merlo M; Taylor MR; Camerini F; Sinagra G
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):6-12. PubMed ID: 20814312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics and heart failure: tailor-made therapy?
    Iyengar S; Abraham WT
    Congest Heart Fail; 2004; 10(6):273, 288. PubMed ID: 15591840
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacogenomics of carvedilol: the stereo-selective metabolism angle.
    Parker BM; Rogers SL; Lymperopoulos A
    Pharmacogenomics; 2018 Sep; 19(14):1089-1093. PubMed ID: 30086658
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic heart failure: beta-blockers and pharmacogenetics.
    Azuma J; Nonen S
    Eur J Clin Pharmacol; 2009 Jan; 65(1):3-17. PubMed ID: 18839161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential applications of pharmacogenomics to heart failure therapies.
    Parikh KS; Ahmad T; Fiuzat M
    Heart Fail Clin; 2014 Oct; 10(4):599-606. PubMed ID: 25217435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.